Hyperparathyroidism‐jaw tumour syndrome

.  Chen JD, Morrison C, Zhang C, Kahnoski K, Carpten JD, Teh BT (Van Andel Research Institute, Grand Rapids, MI; Ohio State University Comprehensive Cancer Center, Columbus, OH; and National Human Genome Research Institute, National Insitutes of Health, Bethesda, MD, USA). Hyperparathyroidism‐jaw tu...

Full description

Saved in:
Bibliographic Details
Published in:Journal of internal medicine Vol. 253; no. 6; pp. 634 - 642
Main Authors: Chen, J. D., Morrison, C., Zhang, C., Kahnoski, K., Carpten, J. D., Teh, B. T.
Format: Journal Article Conference Proceeding
Language:English
Published: Oxford, UK Blackwell Science Ltd 01-06-2003
Blackwell Science
Blackwell Publishing Ltd
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:.  Chen JD, Morrison C, Zhang C, Kahnoski K, Carpten JD, Teh BT (Van Andel Research Institute, Grand Rapids, MI; Ohio State University Comprehensive Cancer Center, Columbus, OH; and National Human Genome Research Institute, National Insitutes of Health, Bethesda, MD, USA). Hyperparathyroidism‐jaw tumour syndrome (Minisymposium). J Intern Med 2003; 253: 634–642. Amongst hyperparathyroidism‐related syndromes, hyperparathyroidism‐jaw tumour syndrome is one of the least common and relatively unknown but its clinical and genetic aspects are not less interesting or important. With the recent identification of its genes, we can now better characterize the disease, both clinically and genetically, which will certainly impact the field of endocrinology and oncology. In this article, we review the clinico‐pathological features and genetic basis of this syndrome with the hope that it will create awareness and interest in this disease amongst clinicians and basic scientists.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0954-6820
1365-2796
DOI:10.1046/j.1365-2796.2003.01168.x